Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

Article Types

Countries / Regions

Search Results (99)

Search Parameters:
Keywords = tissue donation

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
15 pages, 1272 KiB  
Article
Gender Differences in Knowledge and Attitudes on Hematopoietic Stem Cell Donation Among Apulian Citizens: An Explorative Study
by Elsa Vitale, Roberto Lupo, Stefano Botti, Chiara Ianne, Alessia Lezzi, Giorgio De Nunzio, Donato Cascio, Ivan Rubbi, Simone Zacchino, Gianandrea Pasquinelli, Doria Valentini, Valeria Soffientini, Valentina De Cecco, Chiara Cannici, Marco Cioce and Luana Conte
Hemato 2025, 6(3), 24; https://doi.org/10.3390/hemato6030024 - 22 Jul 2025
Viewed by 233
Abstract
Background: It is estimated that in Italy, there were 364,000 new diagnoses of neoplasms each year and that the overall incidence of blood cancers was 10% of these. Leukemia and lymphomas represented the ninth and eighth places, respectively, among the causes of death [...] Read more.
Background: It is estimated that in Italy, there were 364,000 new diagnoses of neoplasms each year and that the overall incidence of blood cancers was 10% of these. Leukemia and lymphomas represented the ninth and eighth places, respectively, among the causes of death from neoplasia. Hematopoietic stem cell transplantation represented an effective treatment option for many of these malignancies, and not only that: benign and congenital diseases could also be treated. Objective: To assess knowledge among the Apulian population regarding stem cell donation and factors that could influence this choice, focusing especially on the knowledge of the residents of Puglia, Italy on how stem cells were harvested and their functions, their reasons for joining the National Registry, and the reasons that hold them back from making such a choice. Study Design: An observational and cross-sectional study was conducted, through snowball sampling methodology, until data saturation. An online survey was conducted, which included several Italian associations. The questionnaire administered contained five main sections, such as sociodemographic data, knowledge of the existence of National Registries and their adherence, the nationwide presence of various associations that promote donation, knowledge with respect to the structure, use and functions of stem cells, sources of procurement, such as bone marrow, peripheral blood and umbilical cord, and related procedures, beliefs, attitudes, values, and opinions of the Italian population regarding the topic, and degree of information and education regarding bone marrow donation. Results: A total of 567 Apulian citizens were enrolled. Of these, 75.3% were female and 96.8% were aged between 18 and 65 years. Most of participants were single (46.9%) and married (47.3%) and had a diploma (44.4%), and less had a degree (35.8%). Significant differences were recorded between gender, singles, and married participants, and participants with a diploma or a degree and the items proposed. Conclusions: A true culture of donation in our region was not clearly spread. Although something has been accomplished in recent years in terms of deceased donor donation, still a great deal needs to be achieved for living donation, which encountered a great deal of resistance. It has been deemed necessary to seek winning solutions to this issue in terms of communication and information campaigns, raising awareness and empowering citizens to express consciously their concerns about organs and tissues and to stand in solidarity with those who suffered. Full article
Show Figures

Figure 1

14 pages, 282 KiB  
Article
Knowledge and Attitudes Toward Organ Donation and Transplantation Among Nursing Students: A Multicentre Cross-Sectional Study
by Luca Bertocchi, Cristina Petrucci, Massimo Alex Calzetta, Angelo Dante, Felice Curcio, Loreto Lancia and Cesar Ivan Aviles Gonzalez
Nurs. Rep. 2025, 15(6), 181; https://doi.org/10.3390/nursrep15060181 - 22 May 2025
Viewed by 811
Abstract
Background/Objectives: Organ transplantation is a vital treatment for individuals with advanced chronic-degenerative diseases. However, the global shortage of donated organs remains a significant challenge. Improving knowledge and attitudes could positively impact this issue. This study assessed the knowledge and attitudes of nursing [...] Read more.
Background/Objectives: Organ transplantation is a vital treatment for individuals with advanced chronic-degenerative diseases. However, the global shortage of donated organs remains a significant challenge. Improving knowledge and attitudes could positively impact this issue. This study assessed the knowledge and attitudes of nursing students regarding organ donation and transplantation. Methods: A cross-sectional study was conducted using a previously validated questionnaire administered to 235 second- and third-year undergraduate nursing students from two Italian universities. Results: The response rate was 67.3%. Only 40.4% of students felt adequately informed about transplants and brain death, while 12.8% would not authorise organ transplantation for a family member. Willingness to authorise organ procurement from family members in a brain-dead state was positively associated with being atheist or agnostic (χ2 = 7.235; p = 0.022), being in the third year of study (χ2 = 4.282; p = 0.039) and having positive self-assessed knowledge (χ2 = 8.061; p = 0.005). Conclusions: Nursing students exhibited suboptimal knowledge and positive attitudes toward organ and tissue donation. However, there is a need for health policymakers to implement strategies to raise awareness of the importance of organ donation through school and community programmes and public education campaigns. Full article
31 pages, 13869 KiB  
Article
Development and Validation in Porcine and Human Models of a Bioimpedance Spectroscopy System for the Objective Assessment of Kidney Graft Viability
by David Naranjo-Hernández, Javier Reina-Tosina, Laura M. Roa, Gerardo Barbarov-Rostán, Jorge Calvillo-Arbizu, Alejandro Talaminos-Barroso, Miguel Ángel Pérez-Valdivia and Rafael A. Medina-López
Sensors 2025, 25(9), 2871; https://doi.org/10.3390/s25092871 - 2 May 2025
Viewed by 368
Abstract
This work presents an innovative bioimpedance spectroscopy device, developed as a support tool for decision-making during the evaluation of kidney viability for renal transplantation. Given the increasing demand for organs and the need to optimize donation criteria, the precise and objective assessment of [...] Read more.
This work presents an innovative bioimpedance spectroscopy device, developed as a support tool for decision-making during the evaluation of kidney viability for renal transplantation. Given the increasing demand for organs and the need to optimize donation criteria, the precise and objective assessment of renal graft functionality has become crucial. The device, based on a modular design and adapted to the surgical environment, uses a novel Cole model with a frequency-dependent membrane capacitance, which improves measurement accuracy and repeatability compared to conventional models. Adapting the device for operating room usege involved overcoming significant challenges, such as the need for sterilization and a visual, tactile and acoustic user interface that facilitates device usability. Optimizing the sensing stage has minimized the influence of measurement artifacts, which is crucial for obtaining accurate and representative measurements of renal tissue bioelectrical properties. In addition, a rigorous electrode sterilization protocol was designed, ensuring asepsis during the procedure. The results of tests on porcine renal models demonstrated the device’s ability to monitor pathophysiological changes associated with renal ischemia, with a notable improvement against measurement repeatability. Full article
(This article belongs to the Special Issue Bioimpedance Measurements and Microelectrodes)
Show Figures

Figure 1

12 pages, 1808 KiB  
Article
Mesotherapy with HA and Choline Against Facial Skin Aging: An Open-Label Uncontrolled, Monocentric Study
by Antonio Scarano, Erda Qorri, Andrea Sbarbati, Vincenzo Desiderio and Domenico Amuso
J. Clin. Med. 2025, 14(7), 2303; https://doi.org/10.3390/jcm14072303 - 27 Mar 2025
Cited by 1 | Viewed by 1903
Abstract
Background: Facial aging involves soft and hard tissues with changes that can affect an individual’s self-esteem and aesthetic appearance. Techniques used to counteract these changes include the use of solutions to be injected into the dermis, such as dermal matrix, vitamins, and [...] Read more.
Background: Facial aging involves soft and hard tissues with changes that can affect an individual’s self-esteem and aesthetic appearance. Techniques used to counteract these changes include the use of solutions to be injected into the dermis, such as dermal matrix, vitamins, and antioxidants. B vitamins and choline are vital nutrition for humans and many other animals (vitamin B4), required to produce acetylcholine (ACh). It is considered a neurotransmitter universal methyl donator and of the major membrane constituent phosphatidylcholine (PC) and is crucial for the functioning of cell membranes, including those in skeletal muscle cells. The aim of this study is to evaluate the efficacy and safety of a fragment of HA amino acid and choline in a solution of phosphate buffer system used via mesotherapy. Specifically, state that the primary endpoint was the efficacy assessment using the Scientific Assessment Scale of Skin Quality (SASSQ), while secondary endpoints included safety assessments and patient-reported outcomes. Methods: Forty (40) subjects completed the study. In total, 40 subjects were screened and included in the study. The total duration of the study was 14 months. The first subject was included on 12 January 2019, and the last subject’s last visit was on 14 March 2020. All patients received the SKIN Colin® products by mesotherapy technique for 8 weeks, providing the treatment with the use of 0.5 cc syringes and 13 mm long, 30 G diameter needles. The solution was inoculated into the deep layer of the dermis of the face with a suitable amount of at least 0.2/0.3 mL in the cutaneous points four times every 15 days. Each subject had to be followed for 168 days after the last mesotherapy session. Only enrolled subjects received the HA and choline via mesotherapy. The primary efficacy endpoint was the absolute change in the Scientific Assessment Scale of Skin Quality from Baseline (Day 0) to Day 168. A reduction of at least one point in the SASSQ was considered to reach the endpoint goal. Results: The results of the present investigation show Scientific Assessment Scale of Skin Quality (SASSQ) mean at baseline was 2463 with a standard deviation of 0.36, while at day 168, the mean was 1303 with a standard deviation of 0.36. The difference was statistically significant (p < 0.0001). Also, the GAIS was improved after treatment with Skin Colin®. The assessment of “satisfaction with treatment” was very high by the majority of subjects. Conclusions: In conclusion, our results suggest that a course of treatment with choline via mesotherapy results in an improvement of the Scientific Assessment Scale of Skin Quality. This data is very important for possible fields of application in the treatment of skin and muscle aging. However, the present study has limitations due to the small sample size and the lack of a control group. Full article
(This article belongs to the Special Issue New Advances in Oral and Facial Surgery)
Show Figures

Figure 1

23 pages, 1014 KiB  
Review
Nurse Specialist in the Organ and Tissue Donation Process with Coordination Role: A Scoping Review
by Donato Longo, Nicola Ramacciati and Gian Domenico Giusti
Nurs. Rep. 2025, 15(2), 39; https://doi.org/10.3390/nursrep15020039 - 24 Jan 2025
Cited by 1 | Viewed by 2373
Abstract
Background/Objectives: In recent years, the introduction of specialist nurses, such as donation coordinator nurses, has been proposed as a potentially effective strategy to increase the number of donations and improve the quality of the process. However, experiences in this field are still [...] Read more.
Background/Objectives: In recent years, the introduction of specialist nurses, such as donation coordinator nurses, has been proposed as a potentially effective strategy to increase the number of donations and improve the quality of the process. However, experiences in this field are still limited. The aim of this study was to evaluate the impact of the inclusion of this professional in health systems, both in quantitative and qualitative terms. Methods: A scoping review was performed. Studies published from 1990 to 2024 were included regardless of the study design. The bibliographic search was performed on the databases MedLine, Web of Science, Scopus, CINAHL, and PsycInfo and on the search engines EBSCOhost, ProQuest, and Google Scholar. The search strings included keywords such as organ donation, transplant, procurement, and nursing role. The extraction and selection of articles were conducted in accordance with the PRISMA-ScR guidelines and with the methodology of the Joanna Briggs Institute for scoping reviews. The protocol study was prospectively registered with the Open Science Framework database on 3 December 2023, with registration number osf.io/wzxr3. Results: From the included studies, it emerged that the involvement of a nurse coordinator in the donation process is significantly associated with an increase in the number of organ donors and higher rates of family consent to donation. Additionally, the studies highlighted enhanced effectiveness in identifying potential donors and improvements in the training and preparedness of healthcare staff. Conclusions: The nurse coordinator in the donation process can have positive effects both on the management of the process and on the increase in the number of organ and tissue donations. Full article
(This article belongs to the Special Issue Advances in Critical Care Nursing)
Show Figures

Figure 1

17 pages, 8717 KiB  
Article
Effects of RF Electric Currents on Hair Follicle Growth and Differentiation: A Possible Treatment for Alopecia
by María Antonia Martínez-Pascual, Silvia Sacristán, Elena Toledano-Macías, Pablo Naranjo and María Luisa Hernández-Bule
Int. J. Mol. Sci. 2024, 25(14), 7865; https://doi.org/10.3390/ijms25147865 - 18 Jul 2024
Cited by 5 | Viewed by 5302
Abstract
Androgenic alopecia (AGA) is the most common type of alopecia and its treatments involve drugs that have various adverse effects and are not completely effective. Radiofrequency-based therapies (RF) are an alternative for AGA treatment. Although there is increasing clinical evidence of the effectiveness [...] Read more.
Androgenic alopecia (AGA) is the most common type of alopecia and its treatments involve drugs that have various adverse effects and are not completely effective. Radiofrequency-based therapies (RF) are an alternative for AGA treatment. Although there is increasing clinical evidence of the effectiveness of RF for alopecia, its effects at the tissue and cellular level have not been studied in detail. The objective of this study was to analyze ex vivo the potential effect of RF currents used in capacitive resistive electrical transfer (CRET) therapy on AGA. Hair follicles (HFs) were donated by patients with AGA and treated with CRET. AGA-HFs were exposed in vitro to intermittent 448 kHz electric current in subthermal conditions. Cell proliferation (Ki67), apoptosis (TUNEL assay), differentiation (β-catenin), integrity (collagen and MMP9), thickness of the epidermis surrounding HF, proportion of bulge cells and melanoblasts in AGA-HF were analyzed by immunohistochemistry. CRET increased proliferation and decreased death of different populations of AGA-HF cells. In addition, the melanoblasts increased in bulge and the epidermis surrounding the hair follicle thickened. These results support the effectiveness of RF-based therapies for the treatment of alopecia. However, clinical trials are necessary to know the true effectiveness of CRET therapy and other RF therapies for AGA treatment. Full article
(This article belongs to the Special Issue Molecular Insights into Hair Regeneration)
Show Figures

Figure 1

9 pages, 1295 KiB  
Brief Report
Results of the Phase 1 Open-Label Safety Study of Umbilical Cord Lining Mesenchymal Stromal/Stem Cells (Corlicyte®) to Heal Chronic Diabetic Foot Ulcers
by Cecilia C. Low Wang, Tae Chong, Garrett Moore, Benjamin Echalier, Nicola Haakonsen, James E. Carter, David Mathes, Judith Hsia, Toan Thang Phan, Ivor J. Lim and Brian M. Freed
Biomedicines 2024, 12(6), 1375; https://doi.org/10.3390/biomedicines12061375 - 20 Jun 2024
Cited by 3 | Viewed by 2506
Abstract
Background: Mesenchymal stromal/stem cells (MSCs) play a critical role in wound healing. Corlicyte® is an MSC product derived from allogeneic umbilical cord tissue donated under an institutional review board-approved protocol and processed in accordance with section 501(a)(2)(B) of the Federal Food, Drug, [...] Read more.
Background: Mesenchymal stromal/stem cells (MSCs) play a critical role in wound healing. Corlicyte® is an MSC product derived from allogeneic umbilical cord tissue donated under an institutional review board-approved protocol and processed in accordance with section 501(a)(2)(B) of the Federal Food, Drug, and Cosmetic Act. This open-label phase 1 trial was performed under a United States Food and Drug Administration Investigational New Drug Application to establish the safety and tolerability of Corlicyte® in patients with diabetes and chronic diabetic foot ulcer (DFU). Methods: Escalating doses were applied topically twice a week for up to 8 weeks after ulcer debridement, wound photography, and measurement. Subjects were followed for 4 weeks after the treatment phase. Adverse events were assessed at every visit. Results: Nine subjects in 2 dosing cohorts completed the trial. No subjects experienced a serious adverse reaction to Corlicyte® or the development of anti-human leukocyte antigen (HLA) antibodies. Sixty percentage of subjects in the lower dose cohort experienced ulcer closure by Day 70 of follow-up, while the mean ulcer size was reduced by 54–67% in the other subjects. Conclusions: Topical administration of Corlicyte®, a novel biologic therapy consisting of allogeneic umbilical cord lining MSCs, appeared safe and tolerable and resulted in a significant decrease in ulcer area, demonstrating its potential as a therapy for healing of chronic DFU. Full article
Show Figures

Figure 1

18 pages, 744 KiB  
Review
The Role of Ergothioneine in Red Blood Cell Biology: A Review and Perspective
by Tiffany A. Thomas, Richard O. Francis, James C. Zimring, Joseph P. Kao, Travis Nemkov and Steven L. Spitalnik
Antioxidants 2024, 13(6), 717; https://doi.org/10.3390/antiox13060717 - 13 Jun 2024
Cited by 6 | Viewed by 4916
Abstract
Oxidative stress can damage tissues and cells, and their resilience or susceptibility depends on the robustness of their antioxidant mechanisms. The latter include small molecules, proteins, and enzymes, which are linked together in metabolic pathways. Red blood cells are particularly susceptible to oxidative [...] Read more.
Oxidative stress can damage tissues and cells, and their resilience or susceptibility depends on the robustness of their antioxidant mechanisms. The latter include small molecules, proteins, and enzymes, which are linked together in metabolic pathways. Red blood cells are particularly susceptible to oxidative stress due to their large number of hemoglobin molecules, which can undergo auto-oxidation. This yields reactive oxygen species that participate in Fenton chemistry, ultimately damaging their membranes and cytosolic constituents. Fortunately, red blood cells contain robust antioxidant systems to enable them to circulate and perform their physiological functions, particularly delivering oxygen and removing carbon dioxide. Nonetheless, if red blood cells have insufficient antioxidant reserves (e.g., due to genetics, diet, disease, or toxin exposure), this can induce hemolysis in vivo or enhance susceptibility to a “storage lesion” in vitro, when blood donations are refrigerator-stored for transfusion purposes. Ergothioneine, a small molecule not synthesized by mammals, is obtained only through the diet. It is absorbed from the gut and enters cells using a highly specific transporter (i.e., SLC22A4). Certain cells and tissues, particularly red blood cells, contain high ergothioneine levels. Although no deficiency-related disease has been identified, evidence suggests ergothioneine may be a beneficial “nutraceutical.” Given the requirements of red blood cells to resist oxidative stress and their high ergothioneine content, this review discusses ergothioneine’s potential importance in protecting these cells and identifies knowledge gaps regarding its relevance in enhancing red blood cell circulatory, storage, and transfusion quality. Full article
(This article belongs to the Special Issue Blood Cells and Redox Homeostasis in Health and Disease)
Show Figures

Figure 1

12 pages, 1256 KiB  
Communication
A Standardized Nomenclature Design for Systematic Referencing and Identification of Animal Cellular Material
by Lisa Schrade, Nancy Mah, Anita Bandrowski, Ying Chen, Johannes Dewender, Sebastian Diecke, Christian Hiepen, Madeline A. Lancaster, Tomas Marques-Bonet, Sira Martinez, Sabine C. Mueller, Christopher Navara, Alessandro Prigione, Stefanie Seltmann, Jaroslaw Sochacki, Magdalena A. Sutcliffe, Vera Zywitza, Thomas B. Hildebrandt and Andreas Kurtz
Animals 2024, 14(11), 1541; https://doi.org/10.3390/ani14111541 - 23 May 2024
Cited by 1 | Viewed by 1990
Abstract
The documentation, preservation and rescue of biological diversity increasingly uses living biological samples. Persistent associations between species, biosamples, such as tissues and cell lines, and the accompanying data are indispensable for using, exchanging and benefiting from these valuable materials. Explicit authentication of such [...] Read more.
The documentation, preservation and rescue of biological diversity increasingly uses living biological samples. Persistent associations between species, biosamples, such as tissues and cell lines, and the accompanying data are indispensable for using, exchanging and benefiting from these valuable materials. Explicit authentication of such biosamples by assigning unique and robust identifiers is therefore required to allow for unambiguous referencing, avoid identification conflicts and maintain reproducibility in research. A predefined nomenclature based on uniform rules would facilitate this process. However, such a nomenclature is currently lacking for animal biological material. We here present a first, standardized, human-readable nomenclature design, which is sufficient to generate unique and stable identifying names for animal cellular material with a focus on wildlife species. A species-specific human- and machine-readable syntax is included in the proposed standard naming scheme, allowing for the traceability of donated material and cultured cells, as well as data FAIRification. Only when it is consistently applied in the public domain, as publications and inter-institutional samples and data are exchanged, distributed and stored centrally, can the risks of misidentification and loss of traceability be mitigated. This innovative globally applicable identification system provides a standard for a sustainable structure for the long-term storage of animal bio-samples in cryobanks and hence facilitates current as well as future species conservation and biomedical research. Full article
(This article belongs to the Collection Recent Advance in Wildlife Conservation)
Show Figures

Figure 1

17 pages, 9578 KiB  
Article
Implementation and Evaluation of a Uterine Manipulation System Incorporated with an Existing Tiltable-Tip Uterine Manipulator for Gynecological Laparoscopy
by Songphon Namkhun, Kovit Khampitak, Apiwat Boonkong and Daranee Hormdee
Appl. Sci. 2024, 14(9), 3851; https://doi.org/10.3390/app14093851 - 30 Apr 2024
Cited by 1 | Viewed by 3054
Abstract
In gynecologic surgery, a uterine manipulator is one of the instruments used to perform the laparoscopy. Throughout the past decade, a number of robotic technology applications used for uterine manipulation during surgery have been designed with the aim of increasing the efficiency, improving [...] Read more.
In gynecologic surgery, a uterine manipulator is one of the instruments used to perform the laparoscopy. Throughout the past decade, a number of robotic technology applications used for uterine manipulation during surgery have been designed with the aim of increasing the efficiency, improving the precision, and reducing the workload of medical assistants. Although the RCM (Remote Center of Motion) mechanism is one of the key features in a Minimally Invasive Surgical (MIS) robot, the preliminary result in this study, in which the RCM mechanism was applied in a uterine manipulation robot, proved that this may cause unpleasant sensations such as irritation or harm to the nearby area during such manipulation. Therefore, a design of a non-RCM 2-DoF (Degree of Freedom) Robotic Uterine Manipulation System, in cooperation with an existing, reusable and tiltable-tip uterine manipulator, for laparoscopic gynecologic surgery has been proposed and evaluated via a mathematical model along with numerical analysis, a 3D uterus model, and a 1:1 uterus manikin model in order to demonstrate the use of the essential functions. According to the experimental results, the maximum load of 500 g has been handled well by the prototype, with the movement ranges of ±150° in the roll panel and ±90° in the pitch panel (0∼90° for anteversion and 0∼−90° for retroversion, if needed, which can be achieved by rotating the instrument to the other side). Furthermore, to verify this new design prior to its use on patients, and also in consideration of the ethics of human experimentation, through extensive testing on five donated soft-tissue cadavers, the proposed robot received positive feedback from all five surgeons performing the experiments and could offer effective uterine manipulation at the angular velocity of 4 °/s (0.67 RPM) with steady delineation of the vaginal fornices to create necessary motions in the pitch and roll panels of 30∼80° and ±15°, respectively, providing efficient visualization of the uterus. These features make this robot a valuable addition to the surgical instruments available to gynecologic surgeons. Full article
Show Figures

Figure 1

31 pages, 1215 KiB  
Review
Current Status and Future Prospects of Stem Cell Therapy for Infertile Patients with Premature Ovarian Insufficiency
by Hye Kyeong Kim and Tae Jin Kim
Biomolecules 2024, 14(2), 242; https://doi.org/10.3390/biom14020242 - 19 Feb 2024
Cited by 13 | Viewed by 10848
Abstract
Premature ovarian insufficiency (POI), also known as premature menopause or premature ovarian failure, signifies the partial or complete loss of ovarian endocrine function and fertility before 40 years of age. This condition affects approximately 1% of women of childbearing age. Although 5–10% of [...] Read more.
Premature ovarian insufficiency (POI), also known as premature menopause or premature ovarian failure, signifies the partial or complete loss of ovarian endocrine function and fertility before 40 years of age. This condition affects approximately 1% of women of childbearing age. Although 5–10% of patients may conceive naturally, conventional infertility treatments, including assisted reproductive technology, often prove ineffective for the majority. For infertile patients with POI, oocyte donation or adoption exist, although a prevalent desire persists among them to have biological children. Stem cells, which are characterized by their undifferentiated nature, self-renewal capability, and potential to differentiate into various cell types, have emerged as promising avenues for treating POI. Stem cell therapy can potentially reverse the diminished ovarian endocrine function and restore fertility. Beyond direct POI therapy, stem cells show promise in supplementary applications such as ovarian tissue cryopreservation and tissue engineering. However, technological and ethical challenges hinder the widespread clinical application of stem cells. This review examines the current landscape of stem cell therapy for POI, underscoring the importance of comprehensive assessments that acknowledge the diversity of cell types and functions. Additionally, this review scrutinizes the limitations and prospects associated with the clinical implementation of stem cell treatments for POI. Full article
(This article belongs to the Collection Feature Papers in Molecular Reproduction)
Show Figures

Figure 1

25 pages, 3585 KiB  
Review
Advances in the Generation of Constructed Cardiac Tissue Derived from Induced Pluripotent Stem Cells for Disease Modeling and Therapeutic Discovery
by Truman J. Roland and Kunhua Song
Cells 2024, 13(3), 250; https://doi.org/10.3390/cells13030250 - 29 Jan 2024
Cited by 6 | Viewed by 4724
Abstract
The human heart lacks significant regenerative capacity; thus, the solution to heart failure (HF) remains organ donation, requiring surgery and immunosuppression. The demand for constructed cardiac tissues (CCTs) to model and treat disease continues to grow. Recent advances in induced pluripotent stem cell [...] Read more.
The human heart lacks significant regenerative capacity; thus, the solution to heart failure (HF) remains organ donation, requiring surgery and immunosuppression. The demand for constructed cardiac tissues (CCTs) to model and treat disease continues to grow. Recent advances in induced pluripotent stem cell (iPSC) manipulation, CRISPR gene editing, and 3D tissue culture have enabled a boom in iPSC-derived CCTs (iPSC-CCTs) with diverse cell types and architecture. Compared with 2D-cultured cells, iPSC-CCTs better recapitulate heart biology, demonstrating the potential to advance organ modeling, drug discovery, and regenerative medicine, though iPSC-CCTs could benefit from better methods to faithfully mimic heart physiology and electrophysiology. Here, we summarize advances in iPSC-CCTs and future developments in the vascularization, immunization, and maturation of iPSC-CCTs for study and therapy. Full article
(This article belongs to the Special Issue Model Systems and Candidate Genes for Inherited Cardiomyopathies)
Show Figures

Figure 1

24 pages, 1918 KiB  
Review
Cardiovascular Tissue Engineering Models for Atherosclerosis Treatment Development
by Linnea Tscheuschner and Abraham R. Tzafriri
Bioengineering 2023, 10(12), 1373; https://doi.org/10.3390/bioengineering10121373 - 29 Nov 2023
Cited by 2 | Viewed by 2860
Abstract
In the early years of tissue engineering, scientists focused on the generation of healthy-like tissues and organs to replace diseased tissue areas with the aim of filling the gap between organ demands and actual organ donations. Over time, the realization has set in [...] Read more.
In the early years of tissue engineering, scientists focused on the generation of healthy-like tissues and organs to replace diseased tissue areas with the aim of filling the gap between organ demands and actual organ donations. Over time, the realization has set in that there is an additional large unmet need for suitable disease models to study their progression and to test and refine different treatment approaches. Increasingly, researchers have turned to tissue engineering to address this need for controllable translational disease models. We review existing and potential uses of tissue-engineered disease models in cardiovascular research and suggest guidelines for generating adequate disease models, aimed both at studying disease progression mechanisms and supporting the development of dedicated drug-delivery therapies. This involves the discussion of different requirements for disease models to test drugs, nanoparticles, and drug-eluting devices. In addition to realistic cellular composition, the different mechanical and structural properties that are needed to simulate pathological reality are addressed. Full article
(This article belongs to the Special Issue Stem Cells for Vascular Tissue Engineering)
Show Figures

Graphical abstract

11 pages, 541 KiB  
Article
Organ Donation Awareness among Family Members of ICU Patients
by Petru Cotrău, Marcel Negrău, Viviana Hodoșan, Adriana Vladu, Cristian Marius Daina, Dorel Dulău, Carmen Pantiș and Lucia Georgeta Daina
Medicina 2023, 59(11), 1966; https://doi.org/10.3390/medicina59111966 - 8 Nov 2023
Cited by 2 | Viewed by 2473
Abstract
Background and Objectives: With one of the lowest donation rates in the European Union, Romania faces challenges in organ donation from brain death donors, within an opt-in system. This study aims to measure the attitudes and knowledge of ICU patient’s relatives toward [...] Read more.
Background and Objectives: With one of the lowest donation rates in the European Union, Romania faces challenges in organ donation from brain death donors, within an opt-in system. This study aims to measure the attitudes and knowledge of ICU patient’s relatives toward organ donation. Materials and Methods: A descriptive cross-sectional study was conducted in the intensive care unit of the Emergency Clinical County Hospital of Oradea, Romania. A 24-item self-administered questionnaire (N = 251) was used to collect data on knowledge about organ and tissue donation and transplantation, as well as the willingness to donate. Results: A high degree of awareness and willingness for organ donation and transplantation was recorded. The main positive predictor of willingness to donate was the perception of helping others by donating their organs after brain death (β = 0.537, OR = 1.711, p < 0.05), and the main negative predictor was the idea that the whole body should be buried intact (β = −0.979, OR = 0.376, p < 0.01). Conclusions: A basic understanding of organ donation and transplantation and favorable attitudes toward organ donation were registered. Families’ interviews for organ donation consent may be affected due to extreme emotional distress. Full article
Show Figures

Figure 1

13 pages, 3643 KiB  
Article
Prostate-Specific Membrane Antigen (PSMA) Expression Predicts Need for Early Treatment in Prostate Cancer Patients Managed with Active Surveillance
by Elham Ahmadi, Simon Wang, Mohammad Gouran-Savadkoohi, Georgia Douvi, Naghmeh Isfahanian, Nicole Tsakiridis, Brent E. Faught, Jean-Claude Cutz, Monalisa Sur, Satish Chawla, Gregory R. Pond, Gregory R. Steinberg, Ian Brown and Theodoros Tsakiridis
Int. J. Mol. Sci. 2023, 24(22), 16022; https://doi.org/10.3390/ijms242216022 - 7 Nov 2023
Cited by 3 | Viewed by 3434
Abstract
Metabolic dysregulation is an early event in carcinogenesis. Here, we examined the expression of enzymes involved in de novo lipogenesis (ATP-citrate lyase: ACLY), glucose uptake (Glucose Transporter 1: GLUT1), and folate–glutamate metabolism (Prostate-Specific Membrane Antigen: PSMA) as potential biomarkers of risk for early [...] Read more.
Metabolic dysregulation is an early event in carcinogenesis. Here, we examined the expression of enzymes involved in de novo lipogenesis (ATP-citrate lyase: ACLY), glucose uptake (Glucose Transporter 1: GLUT1), and folate–glutamate metabolism (Prostate-Specific Membrane Antigen: PSMA) as potential biomarkers of risk for early prostate cancer progression. Patients who were managed initially on active surveillance with a Gleason score of 6 or a low-volume Gleason score of 7 (3 + 4) were accrued from a prostate cancer diagnostic assessment program. Patients were asked to donate their baseline diagnostic biopsy tissues and permit access to their clinical data. PSMA, GLUT1, and ACLY expression were examined with immunohistochemistry (IHC) in baseline biopsies, quantitated by Histologic Score for expression in benign and malignant glands, and compared with patient time remaining on active surveillance (time-on-AS). All three markers showed trends for elevated expression in malignant compared to benign glands, which was statistically significant for ACLY. On univariate analysis, increased PSMA and GLUT1 expression in malignant glands was associated with shorter time-on-AS (HR: 5.06, [CI 95%: 1.83–13.94] and HR: 2.44, [CI 95%: 1.10–5.44], respectively). Malignant ACLY and benign gland PSMA and GLUT1 expression showed non-significant trends for such association. On multivariate analysis, overexpression of PSMA in malignant glands was an independent predictor of early PC progression (p = 0.006). This work suggests that the expression of metabolic enzymes determined by IHC on baseline diagnostic prostate biopsies may have value as biomarkers of risk for rapid PC progression. PSMA may be an independent predictor of risk for progression and should be investigated further in systematic studies. Full article
(This article belongs to the Special Issue Novel Researches and Perspectives on Prostate Cancer)
Show Figures

Figure 1

Back to TopTop